Brindley C - Search Results

1

Studies of the mode of action of antitumour triazenes and triazines-III. Metabolism studies on hexamethylmelamine.

Brindley C, Gescher A, Langdon SP, Broggini M, Colombo T, D'Incalci M. Brindley C, et al. Biochem Pharmacol. 1982 Mar 1;31(5):625-31. doi: 10.1016/0006-2952(82)90441-5. Biochem Pharmacol. 1982. PMID: 6805472

2

Studies of the metabolism of dimethylformamide in mice.

Brindley C, Gescher A, Ross D. Brindley C, et al. Chem Biol Interact. 1983 Aug 1;45(3):387-92. doi: 10.1016/0009-2797(83)90085-6. Chem Biol Interact. 1983. PMID: 6883579 No abstract available.

3

Studies of the pharmacology of N-methylformamide in mice.

Brindley C, Gescher A, Harpur ES, Ross D, Slack JA, Threadgill MD, Whitby H. Brindley C, et al. Cancer Treat Rep. 1982 Nov;66(11):1957-65. Cancer Treat Rep. 1982. PMID: 6814756

4

Phase I clinical trial of mitozolomide.

Newlands ES, Blackledge G, Slack JA, Goddard C, Brindley CJ, Holden L, Stevens MF. Newlands ES, et al. Among authors: brindley cj. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):801-5. Cancer Treat Rep. 1985. PMID: 4016790

5

Plasma and tissue disposition of mitozolomide in mice.

Brindley CJ, Antoniw P, Newlands ES. Brindley CJ, et al. Br J Cancer. 1986 Jan;53(1):91-7. doi: 10.1038/bjc.1986.13. Br J Cancer. 1986. PMID: 3456242 Free PMC article.

6

Activity and distribution studies of etoposide and mitozolomide in vivo and in vitro against human choriocarcinoma cell lines.

Brindley CJ, Pedley RB, Antoniw P, Newlands ES. Brindley CJ, et al. Cancer Chemother Pharmacol. 1987;19(3):221-5. doi: 10.1007/BF00252976. Cancer Chemother Pharmacol. 1987. PMID: 3581415

7

Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma.

Brindley CJ, Antoniw P, Newlands ES, Bagshawe KD. Brindley CJ, et al. Cancer Chemother Pharmacol. 1985;15(1):66-71. doi: 10.1007/BF00257298. Cancer Chemother Pharmacol. 1985. PMID: 4039984

8

Percutaneous absorption of co-administered N-methyl-2-[14C]pyrrolidinone and 2-[14C]pyrrolidinone in the rat.

Midgley I, Hood AJ, Chasseaud LF, Brindley CJ, Baughman S, Allan G. Midgley I, et al. Among authors: brindley cj. Food Chem Toxicol. 1992 Jan;30(1):57-64. doi: 10.1016/0278-6915(92)90137-a. Food Chem Toxicol. 1992. PMID: 1544607

9

Metabolic fate of 14C-camostat mesylate in man, rat and dog after intravenous administration.

Midgley I, Hood AJ, Proctor P, Chasseaud LF, Irons SR, Cheng KN, Brindley CJ, Bonn R. Midgley I, et al. Among authors: brindley cj. Xenobiotica. 1994 Jan;24(1):79-92. doi: 10.3109/00498259409043223. Xenobiotica. 1994. PMID: 8165824

10

Dose-proportional pharmacokinetics of cefepime in rats.

Brindley CJ, Brodie RR, Cook SC, Oldfield PR, Chasseaud LF, Barbhaiya RH. Brindley CJ, et al. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:9-14. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters